Werner Sieghart

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

α6GABAA receptors as novel targets for ADHD therapy: A proof-of-concept study in MK-801-treated juvenile mice.

α6GABAA receptors as novel targets for ADHD therapy: A proof-of-concept study in MK-801-treated juvenile mice.

Journal: European journal of pharmacology

Published: May 05, 2026

The Concise Guide to PHARMACOLOGY 2025/26: Ion channels.

The Concise Guide to PHARMACOLOGY 2025/26: Ion channels.

Journal: British journal of pharmacology

Published: December 29, 2025

IUPHAR Review: Alpha6-containing GABAA receptors - Novel targets for the treatment of schizophrenia.

IUPHAR Review: Alpha6-containing GABAA receptors - Novel targets for the treatment of schizophrenia.

Journal: Pharmacological research

Published: December 03, 2024

Why Can Modulation of α6-Containing GABAA Receptors Reduce the Symptoms of Multiple Neuropsychiatric Disorders?

Why Can Modulation of α6-Containing GABAA Receptors Reduce the Symptoms of Multiple Neuropsychiatric Disorders?

Journal: Archives of pharmacology and therapeutics

Published: January 29, 2024

The Concise Guide to PHARMACOLOGY 2023/24: Ion channels.

The Concise Guide to PHARMACOLOGY 2023/24: Ion channels.

Journal: British journal of pharmacology

Published: December 20, 2023

Cerebellar α6GABAA Receptors as a Therapeutic Target for Essential Tremor: Proof-of-Concept Study with Ethanol and Pyrazoloquinolinones.

Cerebellar α6GABAA Receptors as a Therapeutic Target for Essential Tremor: Proof-of-Concept Study with Ethanol and Pyrazoloquinolinones.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: December 29, 2022

GABAA receptors in GtoPdb v.2021.3.

GABAA receptors in GtoPdb v.2021.3.

Journal: IUPHAR/BPS guide to pharmacology CITE

Published: January 10, 2022

Targeting α6GABAA receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models.

Targeting α6GABAA receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 23, 2021

α6-Containing GABAA Receptors: Functional Roles and Therapeutic Potentials.

α6-Containing GABAA Receptors: Functional Roles and Therapeutic Potentials.

Journal: Pharmacological reviews

Published: January 22, 2021

8-Substituted Triazolobenzodiazepines: In Vitro and In Vivo Pharmacology in Relation to Structural Docking at the α1 Subunit-Containing GABAA Receptor.

8-Substituted Triazolobenzodiazepines: In Vitro and In Vivo Pharmacology in Relation to Structural Docking at the α1 Subunit-Containing GABAA Receptor.

Journal: Frontiers in pharmacology

Published: November 02, 2020

α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia.

α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: October 10, 2020

Immunohistochemical distribution of 10 GABAA receptor subunits in the forebrain of the rhesus monkey Macaca mulatta.

Immunohistochemical distribution of 10 GABAA receptor subunits in the forebrain of the rhesus monkey Macaca mulatta.

Journal: The Journal of comparative neurology

Published: January 10, 2020

Showing 1-12 of 43

Last Updated: 09/26/2026